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primary Sjögren’s syndrome as a disease model
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From Northern and Yorkshire Deaneries Annual Rheumatology Conference
York, UK. 26 September 2012
Background
Despite being a common debilitating symptom in many
chronic conditions such as autoimmune diseases or
cancers, the pathophysiology of fatigue is still unclear.
Unsurprisingly, there is no effective treatment for sufferers
[1]. Using primary Sjögren’s Syndrome (pSS) as a disease
model, this study aimed to determine biomarkers of fatigue
and to better understand its pathophysiology.
Methods
Serum samples from pSS patients with different fatigue
levels and healthy controls were analysed using cyto-
metric bead array (CBA) and mass spectrometry-based
label-free quantitative proteomics. The CBA, proteomic
and clinical data were statistically analysed for their rela-
tionship with fatigue.
Results
Statistical analysis concluded that fatigue was negatively
correlated with IP10, IL12p70, ESR and IgG, but posi-
tively correlated with platelets and C4 (p-value <0.05,
Benjamini-Hochberg correction). Moreover, most pro-
tein levels were significantly higher in patients compared
to healthy controls (p-value <0.05). An observed pattern
was apparent that protein levels of patients with high
fatigue lie between healthy controls and low fatigue
patients. Additionally, Multiple linear regression analysis
identified low IgG, high platelets and low IFNa as key
predictive factors for fatigue. Furthermore, after quanti-
tation and identification, the proteomic analysis con-
firmed 9 proteins to be significantly down-regulated and
3 proteins to be significantly up-regulated (p-value
<0.05) in patients with high fatigue compared to those
with low fatigue. The results also indicated that there
was influence of confounders in the analysis, suggested
by different symptoms being significantly correlated
with similar proteins.
Discussion
Based on the observations, it is indicated that insuffi-
cient levels of serum inflammation markers are features
of pSS patients suffering from fatigue.
Conclusion
Using different approaches, we have identified 19 poten-
tial biomarkers for fatigue that is hoped to add our
understanding of fatigue.
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